206 related articles for article (PubMed ID: 37490181)
21. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424
[TBL] [Abstract][Full Text] [Related]
22. m6A RNA Methylation Controls Proliferation of Human Glioma Cells by Influencing Cell Apoptosis.
Li F; Zhang C; Zhang G
Cytogenet Genome Res; 2019; 159(3):119-125. PubMed ID: 31639789
[TBL] [Abstract][Full Text] [Related]
23. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
25. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.
Han H; Fan G; Song S; Jiang Y; Qian C; Zhang W; Su Q; Xue X; Zhuang W; Li B
Blood; 2021 Mar; 137(12):1603-1614. PubMed ID: 32967010
[TBL] [Abstract][Full Text] [Related]
26. Decomposition of RNA methylome reveals co-methylation patterns induced by latent enzymatic regulators of the epitranscriptome.
Liu L; Zhang SW; Zhang YC; Liu H; Zhang L; Chen R; Huang Y; Meng J
Mol Biosyst; 2015 Jan; 11(1):262-74. PubMed ID: 25370990
[TBL] [Abstract][Full Text] [Related]
27. METTL3 regulates hippocampal gene transcription via N6-methyladenosine methylation in sevoflurane-induced postoperative cognitive dysfunction mouse.
He B; Wang J
Aging (Albany NY); 2021 Oct; 13(19):23108-23118. PubMed ID: 34611079
[TBL] [Abstract][Full Text] [Related]
28. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
[TBL] [Abstract][Full Text] [Related]
29. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
30. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract][Full Text] [Related]
31. The METTL3-m
Maldonado López A; Capell BC
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34209046
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
33. Role of m6A RNA Methylation in Thyroid Cancer Cell Lines.
Allegri L; Baldan F; Molteni E; Mio C; Damante G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232810
[TBL] [Abstract][Full Text] [Related]
34. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
35. m6A RNA methylation facilitates pre-mRNA 3'-end formation and is essential for viability of Toxoplasma gondii.
Holmes MJ; Padgett LR; Bastos MS; Sullivan WJ
PLoS Pathog; 2021 Jul; 17(7):e1009335. PubMed ID: 34324585
[TBL] [Abstract][Full Text] [Related]
36. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
[TBL] [Abstract][Full Text] [Related]
37. RNA m6A methylation regulators in liver cancer.
Xu Q; Ren N; Ren L; Yang Y; Pan J; Shang H
Cancer Cell Int; 2024 Jan; 24(1):1. PubMed ID: 38166832
[TBL] [Abstract][Full Text] [Related]
38. NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.
Li Q; Li X; Tang H; Jiang B; Dou Y; Gorospe M; Wang W
J Cell Biochem; 2017 Sep; 118(9):2587-2598. PubMed ID: 28247949
[TBL] [Abstract][Full Text] [Related]
39. N6-methyladenosine-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma.
Wu Z; Lin Y; Wei N
Cancer Sci; 2023 Jan; 114(1):129-141. PubMed ID: 36086906
[TBL] [Abstract][Full Text] [Related]
40. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
